• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

HSKA:US

18.1300 USD 0.2400 1.34%

As of 17:10:00 ET on 12/24/2014.

Snapshot for Heska Corp (HSKA)

Open: 17.9300 Day's Range: 17.8900 - 18.6300 Volume: 66,763
Previous Close: 17.8900 52wk Range: 8.0410 - 18.6300 1-Yr Rtn: +122.18%

Stock Chart for HSKA

No chart data available.
  • HSKA:US 18.1300
  • 1D
  • 1M
  • 1Y
17.8900
Interactive HSKA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HSKA

Current P/E Ratio (ttm) 37.7708
Estimated P/E(12/2014) 40.4688
Relative P/E vs. SPX 2.0487
Earnings Per Share (USD) (ttm) 0.4800
Est. EPS (USD) (12/2014) 0.4480
Est. PEG Ratio 1.6188
Market Cap (M USD) 114.58
Shares Outstanding (M) 6.32
30 Day Average Volume 34,687
Price/Book (mrq) 2.0648
Price/Sale (ttm) 1.2030
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 02/25/2013
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HSKA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HSKA

Heska Corporation discovers, develops, manufactures, and markets companion animal health products, primarily for dogs, cats, and horses. The Company also offers diagnostic and patient monitoring equipment, as well as diagnostic laboratory products in the United States and Europe.

Robert B GrieveChairman/Co-FounderKevin S WilsonPresident/CEO
Michael J McGinley "Mike"President:BiologicalsJason A NapolitanoExec VP/CFO/Secretary
More Company Profile & Key Executives for HSKA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil